TransMedics, Inc.

TransMedics, Inc. is a medical device company based in Andover, Massachusetts, founded in 1998 by Dr. Waleed Hassanein. The company specializes in developing organ care systems (OCS) that enhance the preservation, assessment, and viability of donor organs for transplantation. The core product line includes the Organ Care System, which maintains organs in a warm, functioning state during transport. This technology supports multiple organs, including the heart, lungs, liver, and kidneys. Key products include the OCS Heart System, FDA-approved in 2015; the OCS Lung System, approved in 2018; and the OCS Liver System, approved in 2021. TransMedics is committed to advancing organ preservation technology, supported by research and development initiatives, including recent NIH grants. TransMedics serves transplant centers, hospitals, and healthcare providers, playing a vital role in improving transplant outcomes and addressing the need for better organ preservation. The company went public in 2019 and trades on the Nasdaq Global Market under the ticker symbol TMDX.

• Employees730
• Founded1998
• Annual Revenue$441540000
• Total Funding$874369314